100000 - Document - Document and Entity Information
link:presentationLink
link:calculationLink
link:definitionLink
100010 - Statement - Condensed Consolidated Balance Sheets
link:presentationLink
link:calculationLink
link:definitionLink
100020 - Disclosure - Leases - Summary of Future Minimum Operating Lease Payments (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
100030 - Disclosure - Long-Term Debt - Future principal payments for the Company's debt (Details) 2
link:presentationLink
link:calculationLink
link:definitionLink
100040 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100050 - Statement - Condensed Consolidated Statements of Operations (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100060 - Statement - Condensed Consolidated Statements of Comprehensive Loss (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100070 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100080 - Statement - Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) (Parenthetical)
link:presentationLink
link:calculationLink
link:definitionLink
100090 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)
link:presentationLink
link:calculationLink
link:definitionLink
100100 - Disclosure - Organization and Nature of Business
link:presentationLink
link:calculationLink
link:definitionLink
100110 - Disclosure - Summary of Significant Accounting Policies
link:presentationLink
link:calculationLink
link:definitionLink
100120 - Disclosure - Cash, Cash Equivalents, Restricted Cash Equivalents and Marketable Securities
link:presentationLink
link:calculationLink
link:definitionLink
100130 - Disclosure - Fair Value Measurements
link:presentationLink
link:calculationLink
link:definitionLink
100140 - Disclosure - Accrued Expenses
link:presentationLink
link:calculationLink
link:definitionLink
100150 - Disclosure - Evaluation Agreements
link:presentationLink
link:calculationLink
link:definitionLink
100160 - Disclosure - Collaborative Arrangements
link:presentationLink
link:calculationLink
link:definitionLink
100170 - Disclosure - Related Party Transactions
link:presentationLink
link:calculationLink
link:definitionLink
100180 - Disclosure - Leases
link:presentationLink
link:calculationLink
link:definitionLink
100190 - Disclosure - Warrants
link:presentationLink
link:calculationLink
link:definitionLink
100200 - Disclosure - Stockholders' Equity
link:presentationLink
link:calculationLink
link:definitionLink
100210 - Disclosure - Equity Based Compensation
link:presentationLink
link:calculationLink
link:definitionLink
100220 - Disclosure - Commitments and Contingencies
link:presentationLink
link:calculationLink
link:definitionLink
100230 - Disclosure - Long-Term Debt
link:presentationLink
link:calculationLink
link:definitionLink
100240 - Disclosure - Income Taxes
link:presentationLink
link:calculationLink
link:definitionLink
100250 - Disclosure - Net Loss Per Share
link:presentationLink
link:calculationLink
link:definitionLink
100260 - Disclosure - Subsequent Events
link:presentationLink
link:calculationLink
link:definitionLink
100270 - Disclosure - Summary of Significant Accounting Policies (Policies)
link:presentationLink
link:calculationLink
link:definitionLink
100280 - Disclosure - Summary of Significant Accounting Policies (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100290 - Disclosure - Cash, Cash Equivalents, Restricted Cash Equivalents and Marketable Securities (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100300 - Disclosure - Fair Value Measurements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100310 - Disclosure - Accrued Expenses (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100320 - Disclosure - Evaluation Agreements (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100330 - Disclosure - Related Party Transactions (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100340 - Disclosure - Leases (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100350 - Disclosure - Equity Based Compensation (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100360 - Disclosure - Long Term Debt (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100370 - Disclosure - Net Loss Per Share (Tables)
link:presentationLink
link:calculationLink
link:definitionLink
100380 - Disclosure - Organization and Nature of Business - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100390 - Disclosure - Summary of Significant Accounting Policies - Reconciliation of cash, cash equivalents and restricted cash equivalents (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100400 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100410 - Disclosure - Cash Equivalents, Restricted Cash Equivalents and Marketable Securities (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100420 - Disclosure - Cash, Cash Equivalents, Restricted Cash Equivalents and Marketable Securities - Summary of ash, cash equivalents, restricted cash equivalents and marketable securities (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100430 - Disclosure - Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100440 - Disclosure - Fair Value Measurements - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100450 - Disclosure - Fair Value Measurement - Unobservable inputs used in the fair value Measurement (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100460 - Disclosure - Fair Value Measurements - Summary of the changes in the fair value of the Liability (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100470 - Disclosure - Accrued Expenses - Schedule of Accrued Expenses (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100480 - Disclosure - Evaluation Agreements - Additional information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100490 - Disclosure - Collaborative Arrangements (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100500 - Disclosure - Related Party Transactions - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100510 - Disclosure - Related Party Transactions - Schedule of Amounts Charged for Services and Rent (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100520 - Disclosure - Leases - Summary of consolidated balance sheets and statements of cash flow related to leases (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100530 - Disclosure - Leases - Summary of Future Minimum Operating Lease Payments (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100540 - Disclosure - Leases - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100550 - Disclosure - Warrants - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100560 - Disclosure - Stockholders' Equity - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100570 - Disclosure - Equity-Based Compensation - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100580 - Disclosure - Equity-Based Compensation - Summary of Stock Option Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100590 - Disclosure - Equity-Based Compensation - Summary of Restricted Stock Unit and Award Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100600 - Disclosure - Equity-Based Compensation - Summary of Profits Interests Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100610 - Disclosure - Equity-Based Compensation - Summary of Unit Options Activity (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100620 - Disclosure - Equity-Based Compensation - Summary of Components of Equity-based Compensation Expense (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100630 - Disclosure - Commitments and Contingencies - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100640 - Disclosure - Long-Term Debt (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100650 - Disclosure - Long-Term Debt - Future principal payments for the Company's debt (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100660 - Disclosure - Income Taxes - Additional Information (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100670 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Class A Common Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100680 - Disclosure - Net Loss Per Share - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details)
link:presentationLink
link:calculationLink
link:definitionLink
100690 - Disclosure - Subsequent Events (Additional Information) (Details)
link:presentationLink
link:calculationLink
link:definitionLink
Collaborative Arrangements
Collaborative Arrangement, Accounting Policy [Policy Text Block]
Debt Instrument, Unamortized Discount (Premium), Net
Less: amount representing debt discount
Less: amount representing debt discount
Statement [Line Items]
Statement [Line Items]
Liabilities, Fair Value Disclosure [Abstract]
Liabilities:
Debt Instrument, Interest Rate During Period
Interest Rate During Period
Interest Rate On Loan
Debt Instrument [Axis]
Recently adopted accounting pronouncements policy text block
Recently Adopted Accounting Pronouncements Policy [Text Block]
Recently Adopted Accounting Pronouncements
Plan Name [Domain]
Plan Name
Organizational Transactions.
Organizational Transactions [Member]
Organizational Transactions [Member]
Shares Issuable Pursuant To The ESPP [Member]
Shares Issuable Pursuant To The ESPP [Member]
Shares issuable pursuant to the ESPP.
Shares issuable pursuant to the ESPP
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Cash, Cash Equivalents and Investments [Table Text Block]
Summary of cash, cash equivalents, restricted cash equivalents and marketable securities
Available-for-Sale Securities [Member]
Marketable securities
Common Unit, Outstanding
Common stock, shares outstanding
Common units outstanding
Fair Value, Recurring and Nonrecurring [Table]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]
Debt Security, Corporate, US [Member]
Corporate debt securities
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Interest Paid, Excluding Capitalized Interest, Operating Activities
Cash paid for interest
Other comprehensive loss
Other Comprehensive Income (Loss), Tax [Abstract]
Weighted Average Exercise Price per Share, Exercisable at June 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Cash, Cash Equivalents, and Marketable Securities [Text Block]
Cash Equivalents, Restricted Cash Equivalents and Marketable Securities
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV
Fair Value, Inputs, Level 2 [Member]
Level 2
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Lessee, Operating Lease, Description
RMS-ICL
Rani Management Service and In Cube Labs LLC [Member]
Rani Management Service and In Cube Labs LLC [Member]
Line Of Credit Available To be Drawn
Line Of Credit Available To be Drawn
Line of credit available to be drawn
Accrued Liabilities [Abstract]
Less: current portion of long-term debt
Current portion of long-term debt
Total long-term debt, less current portion
Long-Term Debt, Current Maturities
Lessee, Operating Leases [Text Block]
Leases
Commitments and Contingencies Disclosure [Text Block]
Commitments and Contingencies
Derivative Liability, Fair Value, Gross Liability, Total
Derivative Liability, Subject to Master Netting Arrangement, before Offset
Fair Value (in thousands)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]
Summary of the Changes in the Fair Value of the Company’s Liability
Non Corresponding Class A Units [Member]
Non Corresponding Class A Units [Member]
Non Corresponding Class A Units [Member]
Non-corresponding Class A Units
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Payments for Operating Activities [Abstract]
Cash paid for amounts included in lease liabilities:
Related Party Transaction [Line Items]
Related Party Transaction [Line Items]
Document Information [Table]
Capital Units by Class [Axis]
Stockholders' Equity
Equity [Text Block]
Derivative, Term of Contract
Derivative, term of contract
Class of Warrant or Right [Axis]
Class of Warrant or Right
Debt Securities, Available-for-Sale, Unrealized Loss
Gross Unrealized loss
Gross Unrealized loss
Award Date [Axis]
Sale of Stock [Domain]
Sale of Stock
Cash and Cash Equivalents [Domain]
Cash and Cash Equivalents
Long-Term Debt, Gross
Total long-term debt
Long-Term Debt, Gross, Total
Line of Credit Facility, Remaining Borrowing Capacity
Remaining Borrowing Capacity
Beneficial Interest Liability
Adjustment of tax benefit
Entity Central Index Key
Entity Central Index Key
Series E Warrants
Series E Warrants [Member]
Series e warrants member.
Share Based Compensation Arrangements By Share Based Payment Award Options Grants As Replacement Awards In Period Weighted Average Exercise Price
Share Based Compensation Arrangements By Share Based Payment Award Options Grants As Replacement Awards In Period Weighted Average Exercise Price
Weighted Average Exercise Price per Share, Granted as replacement awards
Warrant [Member]
Preferred unit warrant liability
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Number of options, Forfeited
Number of options, Forfeited
Increase (Decrease) in Operating Capital [Abstract]
Changes in operating assets and liabilities:
Common Class C [Member]
Common Class C [Member]
Proceeds from Issuance of Debt
Proceeds from issuance of debt
Common stock units issued
Common Stock, Shares, Issued, Total
Common Stock, Shares, Issued
Common stock shares issued
Increase (Decrease) in Prepaid Expense and Other Assets, Total
Increase (Decrease) in Prepaid Expense and Other Assets
Prepaid expenses and other current assets
Award Date [Domain]
Income Statement [Abstract]
Entity Address, State or Province
Entity Address, State or Province
Unaudited interim financial information.
Unaudited Interim Financial Information Policy [Text Block]
Unaudited Interim Condensed Consolidated Financial Statements
Issuance of common stock under employee stock purchase plan
Issuance of common stock under employee stock purchase plan
Stock Issued During Period, Value, Employee Stock Purchase Plan
Revision of Prior Period [Axis]
Class of Warrant or Right [Table]
Loss Contingencies [Table]
Loss Contingencies [Table]
Depletion, Total
Depletion
Stock-based compensation expense
Marketable Securities, Total
Marketable Securities
Marketable securities
Non-controlling Interests Policy Text Block
Non-controlling Interests Policy Text Block
Non-controlling Interest
Percentage of tax benefit to be transferred.
Percentage Of Tax Benefit To Be Transferred
Percentage of tax benefit to be transferred
Aggregate Intrinsic Value, Exercisable at June 30, 2022 (in thousands)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Initial Term Leases Agreement
Initial Term Leases Agreement
Initial Term Leases Agreement
Cover [Abstract]
Subsequent Event [Line Items]
Change in estimated fair value
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease), Total
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Period Increase (Decrease)
Comprehensive Income, Policy [Policy Text Block]
Comprehensive Loss
Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., basic
Earnings Per Share, Basic
Earnings Per Share, Basic, Total
Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.-Basic
Contract with Customer, Asset, after Allowance for Credit Loss, Total
Contract with Customer, Asset, after Allowance for Credit Loss
Contract assets
Operating Lease, Lease Income [Abstract]
Operating Expenses [Abstract]
Operating expenses
One time patent payment to related party
One time patent payment to related party
One time patent payment to related party
Measurement input probability of exit events member.
Measurement Input Probability Of Exit Events [Member]
Measurement Input Probability Of Exit Events
Schedule of Cash and Cash Equivalents [Table Text Block]
Schedule of Reconciliation of cash, cash equivalents and restricted cash equivalents
evaluation agreements abstract.
Evaluation Agreements [Abstract]
Stock-based compensation expense
Total equity-based compensation
Share-Based Payment Arrangement, Expense
Percentage Of Increase In Monthly Base Rent (Per Year)
Percentage Of Increase In Monthly Base Rent (Per Year)
Percentage of increase in monthly base rent (per year)
Rani LLC-ICL Service Agreement [Member]
Rani LLC-ICL Service Agreement [Member]
Long-Term Debt
Total principal payments
Fair value measurement discount for lack of marketability.
Fair Value Measurement Discount For Lack Of Marketability
Fair value measurement discount for lack of marketability
Contra-research and development expense
Amount Due From Related Party Expense
Amount Due From Related Party Expense
RMS-ICL Service Agreement [Member]
RMS-ICL Service Agreement [Member]
Retained Earnings (Accumulated Deficit), Beginning Balance
Retained Earnings (Accumulated Deficit), Total
Retained Earnings (Accumulated Deficit), Ending Balance
Retained Earnings (Accumulated Deficit)
Accumulated deficit
Accumulated deficit
Plan Name [Axis]
Plan Name
Stock options, outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Number of Options, Outstanding, Ending balance
Number of Options, Outstanding, Beginning balance
upfront payment.
Upfront Payment
Upfront payment
Supplemental Cash Flow Elements [Abstract]
Supplemental disclosures of cash flow information
Assets, Current [Abstract]
Current assets:
Shares reserved for future issuance
Common Stock, Capital Shares Reserved for Future Issuance
Common units reserved for issuance
Preferred Units by Name [Axis]
Preferred Units by Name
Excess Stock, Shares Outstanding
Beneficially number of shares held
Defined Benefit Plan [Table]
Schedule Of Defined Benefit Plans Disclosures [Table]
Issuance of common stock under employee equity plans, net of shares withheld for tax settlement, amount
Adjustments to Additional Paid in Capital, Other
Operating activities, net
Net Cash Provided by (Used in) Operating Activities
Net cash used in operating activities
Operating activities, net
Forfeited, Weighted-Average Grant Date Fair Value
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Accumulated Other Comprehensive Income (Loss), Net of Tax
Comprehensive loss
Accumulated other comprehensive loss
Weighted Average Grant Date Fair Value, Granted
Share based compensation profit interests granted weighted average grant date fair value.
Share Based Compensation Profit Interests Granted Weighted Average Grant Date Fair Value
Lessee, Operating Lease, Term of Contract
Lessee, Operating Lease, Term of Contract
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Property, Plant and Equipment, Net, Ending Balance
Property, Plant and Equipment, Net, Beginning Balance
Property, Plant and Equipment, Net, Total
Property, Plant and Equipment, Net
Property and equipment, net
Lessee, Operating Lease, Liability, to be Paid, Year Four
2027
Share based compensation arrangement by share based payment award equity instruments other than options grants as replacement of profits interests in period.
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants As Replacement Of Profits Interests In Period
Granted as replacement of Profits Interests, Number of Shares
Net Cash Provided by (Used in) Operating Activities [Abstract]
Cash flows from operating activities
Fair Value, Recurring [Member]
Fair Value, Recurring
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
Schedule of Assets and Liabilities Recorded at Fair Value on a Recurring Basis
Warrants and Rights Subject to Mandatory Redemption [Member]
Warrants
Warrants [Member]
Common Stock, Par or Stated Value Per Share
Common stock par value
Fair value measurement expected volatility rate.
Fair Value Measurement Expected Volatility Rate
Fair value measurement expected volatility rate
Measurement Input Type [Domain]
Measurement Input Type
Statement of Cash Flows [Abstract]
Accrued Professional Fees
Accrued professional fees
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name
Pre-funded warrants issued to purchase shares of common stock
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Securities purchase in exchange for warrant
Restricted Stock [Member]
Restricted Stock Awards
Restricted Stock Awards [Member]
Equity Components [Axis]
Equity Components
Entity Address, Address Line One
Entity Address, Address Line One
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Schedule of Computation of Basic and Diluted Net Loss Per Class A Common Share
Related Party Transaction [Table]
Schedule Of Related Party Transactions By Related Party [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Granted, Number of Shares
Granted, number of shares
Subsequent Event Type [Axis]
Subsequent Event Type
Equity Option [Member]
Stock Options [Member]
Stock options
Accounts payable
Accounts payable
Increase (Decrease) in Accounts Payable, Trade
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
Line of Credit Facility, Maximum Borrowing Capacity
Maximum Borrowing Capacity
Debt Securities, Available-for-Sale, Unrealized Gain
Gross unrealized Gains
Stockholders' equity:
Members' Equity [Abstract]
Stockholders' equity / members' deficit:
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Outstanding, Number of Shares, Beginning Balance
Outstanding, Number of Shares, Ending Balance
Significant Accounting Policies [Policy Text Block]
Significant accounting policies.
Significant Accounting Policies
Amendment Flag
Amendment Flag
Accounting Standards Update 2016-02 [Member]
Adoption of Accounting Standards Update 2016-02 [Member]
Net loss attributable to non-controlling interest
Net Income (Loss) Attributable to Noncontrolling Interest, Total
Net Income (Loss) Attributable to Noncontrolling Interest
Net loss attributable to non-controlling interest
Total long-term debt, less current portion
Long-Term Debt and Lease Obligation, Current
Operating lease liabilities
Increase (Decrease) in Operating Lease Liability
Operating lease liabilities
Operating lease liability, net current portion
Operating Lease, Liability, Noncurrent
Operating lease liability, less current portion
Operating Lease, Liability, Noncurrent, Total
Corporate Debt Securities [Member]
Corporate debt securities
Debt Instrument, Name [Domain]
Stock offering price per share
Sale of Stock, Price Per Share
Common unit, price per share
Net Income (Loss)
Net loss attributable to Rani Therapeutics Holdings, Inc.
Net loss attributable to Rani Therapeutics Holdings, Inc.
Net loss per Class A common share attributable to Rani Therapeutics Holdings, Inc.
Lessee, Lease, Description [Table]
Exercisable at June 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Research and Development
Research and Development Expense [Member]
Research and Development Expense
Exchange Of Common Units
Exchange of common units.
Exchanges of non-corresponding Class A Units of Rani LLC
Effect of exchanges of Paired Interests and non-corresponding Class A Units of Rani LLC
Series B Warrants
Series B Warrants [Member]
Series b warrants member.
Equity Component [Domain]
Equity Component
Statistical Measurement [Domain]
Statistical Measurement
General and Administrative Expense, Total
General and Administrative Expense
General and administrative
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
Net loss
Net loss and comprehensive loss
Net loss
Net loss
Preferred Stock, Shares Issued, Total
Preferred Stock, Shares Issued
Preferred stock issued
Monthly base rent for initial term of the lease
Operating Lease, Payments
Operating cash flows used for operating leases
Number of Profit Interests Vested
Share based compensation number of profits interests vested.
Share Based Compensation Number Of Profits Interests Vested
Exercise of options
Proceeds from Stock Options Exercised
Denominator:
Weighted Average Number Of Shares Outstanding Basic and Diluted
Weighted average number Of shares outstanding basic and diluted
Restricted Cash Equivalents, Total
Restricted Cash Equivalents
Restricted cash equivalents
Stock Issued During Period, Shares, Conversion of Units
Effect of exchanges of Paired Interests and non-corresponding Class A Units of Rani LLC
Nonvested at June 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Adjustments to Additional Paid in Capital, Warrant Issued
Issued classified warrants
Issuance of common stock under employee stock purchase plan, net of shares withheld for tax settlement (Shares)
Stock Issued During Period, Shares, Employee Stock Purchase Plans
All Award Types
All Award Types
Net Asset Value Per Share, Beginning Balance
Net Asset Value Per Share, Ending Balance
Net Asset Value Per Share
General Partner Ownership Interest
Limited Liability Company (LLC) or Limited Partnership (LP), Managing Member or General Partner, Ownership Interest
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Weighted Average Exercise Price per Share, Canceled and replaced with stock options
Weighted Average Exercise Price per Share, Forfeited
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative
Class of Stock [Domain]
Class of Stock
Other Comprehensive Income (Loss), Net of Tax, Total
Other Comprehensive Income (Loss), Net of Tax
Other comprehensive loss
Collaborative Arrangements
Collaborative Arrangement Disclosure [Text Block]
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Comprehensive loss
Comprehensive loss attributable to Rani Therapeutics Holdings, Inc.
Common Stock, Shares, Outstanding
Common stock shares outstanding
Ending Balance (shares)
Beginning Balance (shares)
Series A Common Warrants [Member]
Series A Common Warrants [Member]
Series A Common Warrants Member
Preferred stock, par value
Preferred stock, par or stated value per share
Preferred Stock, Par or Stated Value Per Share
Exchange of paired interest.
Exchange of Paired Interest
Exchange of paired interests
Weighted Average [Member]
Weighted Average
Antidilutive Securities [Axis]
Antidilutive Securities
Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Canceled and replaced with Restricted Stock Awards.
Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Canceled and replaced with Restricted Stock Awards
Profits Interests Threshold, Canceled and replaced with restricted stock awards
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity
Proceeds from Issuance or Sale of Equity, Total
Share-Based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block]
Summary of Restricted Stock Unit and Award Activity
Entity Interactive Data Current
Entity Interactive Data Current
Accounting Standards Update [Domain]
Document Quarterly Report
Document Quarterly Report
UNCALLED AMOUNT OF DEBT
UNCALLED AMOUNT OF DEBT
Uncalled amount of debt
Consolidated Entities [Axis]
Consolidated Entities
Tax Receivable Agreement [Member]
Tax Receivable Agreement [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Vested, Weighted-Average Grant Date Fair Value
Related Party Transaction [Domain]
Related Party Transaction
Cash, cash equivalents and restricted cash equivalents, beginning of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Cash and cash equivalents
Cash, cash equivalents and restricted cash equivalents, end of period
Cash, cash equivalents and restricted cash equivalents, end of period
Cash, cash equivalents and restricted cash equivalents, end of period
Related Party Transactions Disclosure [Text Block]
Related Party Transactions
Statement of Financial Position Location, Balance [Axis]
Receivables or net contract assets from agreement
Receivables, Long-term Contracts or Programs, Total
Receivables, Long-Term Contracts or Programs
Statistical Measurement [Axis]
Statistical Measurement
Profits Interests Activity Threshold Forfeitures
Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Forfeitures
Profits Interests Threshold, Forfeited
Gross proceeds from offering
Gross proceeds
Gross Proceeds From Offering
Gross Proceeds from Offering
Assets, Fair Value Disclosure, Total
Assets, Fair Value Disclosure
Total assets
Related and Nonrelated Parties [Domain]
Related Party
Rani Therapeutics Holdings Inc. [Member]
Parent Company [Member]
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Summary of Future Minimum Operating Lease Payments
Commercial Paper [Member]
Commercial paper
Basis of Presentation
Basis of Presentation and Significant Accounting Policies [Text Block]
Basis of Presentation and Accounting
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Granted, Weighted-Average Grant Date Fair Value
Recognized over a weighted-average period
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Interest income and other, net
Interest and Other Income
Research and Development Expense, Policy [Policy Text Block]
Research and Development Costs
Ownership [Domain]
Statement of Income Location, Balance [Axis]
Income Statement Location
Cash and Cash Equivalents [Axis]
Cash and Cash Equivalents
Cash, Cash Equivalents and Marketable Securities
Cash, Cash Equivalents and Marketable Securities
Cash, cash equivalents and marketable securities
Assets
Total assets
Schedule of Long-Term Debt Instruments [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Vested, Number of Shares
Vested, Number of Shares
New Accounting Pronouncements, Policy [Policy Text Block]
Recently Issued Accounting Pronouncements
Entity Address, City or Town
Entity Address, City or Town
South Lake One L L C And Affiliates.
South Lake One L L C And Affiliates [Member]
South Lake One LLC and Affiliates
Equity [Abstract]
Assets, Fair Value Disclosure [Abstract]
Assets:
Payments of Stock Issuance Costs
Stock issuance costs
Schedule of Maturities of Long-Term Debt [Table Text Block]
Schedule of Future Principal Payments for the Company's Debt
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Forfeited, Number of Shares
Forfeited, Number of Shares
Increase net of tax assets
Increase net of tax assets
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs
Balance at end of period
Balance at beginning of period
Increase Decrease In Per Year
Increase Decrease In Per Year
Agreement termination negotiation period
Agreement Termination Negotiation Period
Agreement termination negotiation period.
Debt Instrument, Face Amount
Debt instrument face amount
Revision of Prior Period [Domain]
Share-Based Payment Arrangement [Text Block]
Equity-Based Compensation
Weighted-average discount rate
Operating Lease, Weighted Average Discount Rate, Percent
Fair Value Disclosures [Abstract]
Share based Compensation Arrangement By Share based Payment Award Options Canceled And Replaced Weighted Average Remaining Contractual Term
Share based Compensation Arrangement By Share based Payment Award Options Canceled And Replaced Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term, Canceled and replaced with stock options (in years)
Effects of the IPO and related Organizational Transactions [Member]
Effects of the IPO and related Organizational Transactions [Member]
Deferred Tax Assets, Net of Valuation Allowance, Total
Deferred Tax Assets, Net of Valuation Allowance
Deferred tax asset
Lessee, Lease, Description [Line Items]
Liabilities, Current [Abstract]
Current liabilities:
Profits Interests Activity Threshold Grants
Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Grants
Profits Interests Threshold, Granted
Total accrued expenses and other current liabilities
Accrued Liabilities
Income Taxes Paid, Net, Total
Income Taxes Paid, Net
Cash paid for income taxes
Cash and Cash Equivalents [Member]
Cash Equivalents [Member]
Document Type
Document Type
Accounting Standards Update [Axis]
Share Based Compensation Profit Interests Forfeitures Weighted Average Grant Date Fair Value.
Share Based Compensation Profit Interests Forfeitures Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Forfeited
Title of 12(b) Security
Title of 12(b) Security
Cash and Cash Equivalents, at Carrying Value
Cash and cash equivalents, end of year
Cash and cash equivalents, beginning of year
Cash and cash equivalents
Cash and Cash Equivalents, at Carrying Value, Total
Cash and cash equivalents
Prepaid Interest
Interest income receivable included in prepaid expenses and other current assets
Statement of Financial Position Location, Balance [Domain]
Lessee, Operating Lease, Liability, to be Paid, Year Five
2028
Statement of Stockholders' Equity [Abstract]
Document Fiscal Period Focus
Document Fiscal Period Focus
Research and Development Expense, Total
Research and Development Expense
Research and development
Payment, Tax Withholding, Share-Based Payment Arrangement
Tax withholdings paid on behalf of employees for net share settlement
Total long-term debt, less current portion
Long-term debt, less current portion
Long-Term Debt, Excluding Current Maturities
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Number of Options, Granted
Number of Options, Unit Grants
Restricted Cash and Cash Equivalents, Total
Restricted Cash and Cash Equivalents
Restricted cash equivalents, end of period
Total cash, cash equivalents and restricted cash equivalents
Asset Class [Domain]
Issuance of common stock under employee stock purchase plan
Proceeds from Issuance of common stock under the employee stock purchase plan
Proceeds from Issuance of common stock under the employee stock purchase plan
Weighted Average Remaining Contractual Term, Nonvested at June 30, 2022 (in years)
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Remaining Contractual Term
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Remaining Contractual Term.
Subsequent Event Type [Domain]
Subsequent Event Type
Lessee, Leases [Policy Text Block]
Leases
Measurement Input, Expected Term [Member]
Measurement Input, Expected Term
Member Units [Member]
Profits Interests
US Treasuries [Member]
US Treasuries [Member]
U.S. Treasuries [Member]
U.S. Treasuries
Aggregate Intrinsic Value, Nonvested at June 30, 2022 (in thousands)
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Intrinsic Value
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Intrinsic Value.
Condensed Cash Flow Statement [Table Text Block]
Summary of consolidated balance sheets and statements of cash flow related to leases
Summary of significant accounting policies.
Summary Of Significant Accounting Policies [Line Items]
Summary Of Significant Accounting Policies [Line Items]
Warrant exercise price
Class of Warrant or Right, Exercise Price of Warrants or Rights
Financial Instruments [Domain]
Class of Warrant or Right [Line Items]
Sale of Stock [Axis]
Sale of Stock
Net Cash Provided by (Used in) Investing Activities [Abstract]
Cash flows from investing activities
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Earnings Per Share [Line Items]
Statement of Comprehensive Income [Abstract]
Income Taxes
Income Tax Disclosure [Text Block]
Ownership [Axis]
Consolidated Entities [Domain]
Consolidated Entities
Warrants and Rights Note Disclosure [Abstract]
Paired Interests [Member]
Paired Interests [Member]
Paired Interest [Member]
Paired Interests
Short-Term Debt, Type [Axis]
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Settlements
Settlement of Series E warrants
Credit Facility [Domain]
Share based compensation arrangement by share based payment award equity instruments other than options grants as replacement of profits interests in period weighted average grant date fair value.
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants As Replacement Of Profits Interests In Period Weighted Average Grant Date Fair Value
Granted as replacement of Profits Interests, Weighted-Average Grant Date Fair Value
Condensed Financial Statements [Table Text Block]
Summary of Consolidated Balance Sheets and Statements of Cash Flow related to Leases
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants Weighted Average Remaining Contractual Term
Sharebased Compensation Arrangement By Sharebased Payment Award Options Grants Weighted Average Remaining Contractual Term.
Weighted Average Remaining Contractual Term, Granted (in years)
Depreciation and amortization
Depreciation, Depletion and Amortization, Nonproduction
Depreciation, Depletion and Amortization, Nonproduction, Total
Short-Term Debt, Type [Domain]
Liabilities and Equity [Abstract]
Liabilities and Stockholders' Equity
Document Period End Date
Document Period End Date
Accrued interest
Accrued interest
Net Cash Provided by (Used in) Financing Activities
Net cash provided by financing activities
Common Class A [Member]
Common Class A
Common Class A [Member]
Effective Income Tax Rate Reconciliation, Percent, Total
Effective Income Tax Rate Reconciliation, Percent
Effective income tax rate
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Exchanged paired interests for the Company's Class A common stock
Anti-dilutive securities
Share based compensation arrangement by share based payment award profits interests activity threshold vested.
Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold Vested
Profits Interests Threshold, Vested
Stock-based compensation
APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Common Class B
Common Class B [Member]
Common Class B [Member]
Sales Agreement [Member]
Sales Agreement [Member]
Sales Agreement
Lessee, Operating Lease, Liability, to be Paid, after Year Five
2029
Deferred Revenue, Total
Deferred Revenue
Balance at end of period
Balance at beginning of period
Deferred revenue
Aequanimitas Limited
Aequanimitas Limited [Member]
Aequanimitas Limited
Loan and Security Agreement.
Loan And Security Agreement [Member]
Loan and Security Agreement [Member]
Paycheck Protection Program
Paycheck Protection Program [Member]
Paycheck Protection Program
Trading Symbol
Trading Symbol
Business Combinations [Abstract]
Stockholders' Equity Attributable to Parent, Beginning Balance
Stockholders' Equity Attributable to Parent, Ending Balance
Equity, Attributable to Parent
Total stockholders' equity attributable to Rani Therapeutics Holdings, Inc.
Net unrealized gain (loss) on marketable securities
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax
Net unrealized gain on marketable securities
Class of Warrant or Right, Outstanding
Class of Warrant or Right, Outstanding
Restricted Stock Units (RSUs) [Member]
Restricted Stock Units [Member]
Restricted stock units
Sale of Stock, Number of Shares Issued in Transaction
Sale of common units
Related Party Transactions [Abstract]
Land Subject to Ground Leases
Land Subject to Ground Leases
Capital Unit, Class A [Member]
Class A unit Member
Summary of Components of Equity-based Compensation Expense
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Related party charges
Related Party Transaction Income Expenses From Transactions With Related Party
Related Party Transaction Income Expenses From Transactions With Related Party
Measurement Input Type [Axis]
Measurement Input Type
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Unrecognized equity-based compensation expense
Leases [Abstract]
Share based compensation arrangement by share based payment award options canceled and replaced in period.
Share Based Compensation Arrangement By Share Based Payment Award Options Canceled And Replaced In Period
Number of Options, Canceled and replaced
Number of Options, Canceled and replaced with stock options
Area of Land
Area for Rent For facility in San jose
Use of Estimates, Policy [Policy Text Block]
Use of Estimates
Measurement Input, Discount for Lack of Marketability [Member]
Measurement Input, Discount for Lack of Marketability
Cash, cash equivalents and restricted cash equivalents [Member]
Cash, cash equivalents and restricted cash equivalents [Member]
Cash, equivalents and restricted cash equivalents [Member]
Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards Weighted Average Remaining Contractual Term.
Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards Weighted Average Remaining Contractual Term
Weighted Average Remaining Contractual Term, Granted as replacement awards (in years)
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]
Schedule of deferred revenue balance
Cash and Cash Equivalents, Policy [Policy Text Block]
Cash and Cash Equivalents
Common Unit, Issued
Common Unit Issued
Common units holders
Paired Interest
Paired Interest [Member]
Paired Interest
Restricted stock awards.
Restricted Stock Awards [Member]
Restricted Stock Awards
Measurement Input, Price Volatility [Member]
Measurement Input, Price Volatility
Marketable Securities
Marketable Securities, Policy [Policy Text Block]
Security Exchange Name
Security Exchange Name
Accrued preclinical and clinical trial costs
Accrued preclinical and clinical trial costs 1
Accrued preclinical and clinical trial costs 1
Operating Expenses
Total operating expenses
Secondary sales transactions.
Secondary Sales Transactions [Member]
Secondary Sales Transactions
Class of Stock [Axis]
Class of Stock
Fair Value Disclosures [Text Block]
Fair Value Measurements
Lessee, Operating Lease, Liability, to be Paid, Year Three
2026
Share Based Compensation Profit Interests Weighted Average Grant Date Fair Value.
Share Based Compensation Profit Interests Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Balance at December 31, 2020
Weighted Average Grant Date Fair Value, Balance at September 30, 2021
Conversion of Stock, Shares Converted
Conversion of stock, shares
Subsequent Event
Subsequent Event [Member]
Maximum
Maximum [Member]
Maximum
Liabilities and Equity
Total liabilities and stockholders' equity
InCube Labs, LLC
In Cube Labs L L C [Member]
ICL
ICL
Operating lease right-of-use asset
Operating Lease, Right-of-Use Asset
Prepaid expenses and other current assets
Prepaid Expense, Current
Prepaid Expense, Current, Total
Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., diluted
Earnings Per Share, Diluted
Earnings Per Share, Diluted, Total
Net loss per Class A common share attributable to Rani Therapeutics Holding, Inc., diluted
Entity Ex Transition Period
Entity Ex Transition Period
Liabilities
Total liabilities
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV
Assets, Current
Total current assets
Net Cash Provided by (Used in) Investing Activities
Net cash provided by investing activities
Avenue venture opportunity fund L.P member.
Avenue Venture Opportunity Fund L P [Member]
Avenue Venture Opportunity Fund L.P Member
Issuance of common stock, shares
Stock Issued During Period, Shares, New Issues
Issuance of Class A common stock in connection with the IPO, net of issuance costs $10,686, shares
Weighted Average Exercise Price per Share, Nonvested at June 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price, Beginning Balance
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Entity Filer Category
Entity Filer Category
Activity subsequent to the IPO and related Organizational Transactions [Member]
Activity subsequent to the IPO and related Organizational Transactions [Member]
Takeda Agreement [Member]
Takeda Agreement [Member]
Takeda Agreement [Member]
Equity, Including Portion Attributable to Noncontrolling Interest
Ending Balance
Total stockholders' equity
Beginning Balance
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
Organization and Nature of Business
Payments to Acquire Marketable Securities
Purchases of marketable securities
Purchases of marketable securities
Nonoperating Income (Expense) [Abstract]
Other income (expense), net
Current Fiscal Year End Date
Current Fiscal Year End Date
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Series E Preferred Units
Series E preferred units.
Series E Preferred Units [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value
Fair value of RSAs vested
Noncontrolling Interest [Member]
Noncontrolling Interest [Member]
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Less: Imputed interest
Less: Imputed interest
Award Type [Axis]
Award Type
Stock-based compensation expense
Share-based Payment Arrangement, Noncash Expense, Total
Share-Based Payment Arrangement, Noncash Expense
Related Party Transaction [Axis]
Related Party Transaction
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Aggregate Intrinsic Value, Outstanding
Aggregate Intrinsic Value, Exercisable at September 30, 2021 (in thousands)
Aggregate Intrinsic Value, Outstanding, Ending Balance
Aggregate Intrinsic Value, Outstanding, Beginning Balance
Related and Nonrelated Parties [Axis]
Related Party
Other Accrued Liabilities
Other
Entity Registrant Name
Entity Registrant Name
Number of Options, Granted as replacement awards
Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards In Period Gross.
Share Based Compensation Arrangement By Share Based Payment Award Options Grants As Replacement Awards In Period Gross
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]
Earnings Per Share [Text Block]
Net Loss Per Share
Debt Instrument Maturity Date
Debt Instrument, Maturity Date
Entity Emerging Growth Company
Entity Emerging Growth Company
Net Income (Loss) Available to Common Stockholders, Basic [Abstract]
Numerator:
Money Market Funds [Member]
Money market funds
Money market funds
Weighted-average share outstanding basic
Weighted Average Number of Shares Outstanding, Basic
Weighted Average Number of Shares Outstanding, Basic, Total
Weighted average Class A common share outstanding-basic
Consolidation, Variable Interest Entity, Policy [Policy Text Block]
Variable Interest Entities
Loss Contingencies [Line Items]
Loss Contingencies [Line Items]
Warrants Not Settleable in Cash, Fair Value Disclosure
Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]
Common Stock, Shares Authorized
Common stock shares authorized
Proceeds from Issuance of Common Stock
Proceeds from issuance of common stock
Exchange of shares issued
Proceeds from maturities of marketable securities
Proceeds from Sale and Maturity of Marketable Securities
Cash and Cash Equivalents [Abstract]
Fair Value, Inputs, Level 1 [Member]
Level 1
Debt Disclosure [Abstract]
Long-Term Debt [Text Block]
Long-Term Debt with Detachable Warrants
Long-Term Debt
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Weighted Average Exercise Price per Share, Granted
Weighted Average Exercise Price per Share, Unit Grants
Unrecognized Tax Benefits, Period Increase (Decrease), Total
Unrecognized Tax Benefits, Period Increase (Decrease)
Change in uncertain tax position
Financial Instrument [Axis]
Weighted Average Remaining Contractual Term (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Earnings Per Share, Policy [Policy Text Block]
Net Loss Per Class A Common Share Attributable to Rani Therapeutics Holdings, Inc.
Net Loss Per Class A Common Share Attributable to Rani Holdings
Remeasurement of operating lease right-of-use assets
Remeasurement of operating lease right-of-use assets
Remeasurement of operating lease right-of-use assets
Debt, Policy [Policy Text Block]
Long-Term Debt with Detachable Warrants
General and Administrative
General and Administrative Expense [Member]
General and Administrative Expense
Share Based Compensation Profit Interests Vested Weighted Average Grant Date Fair Value
Share Based Compensation Profit Interests Vested Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Vested
Accrued Payroll Taxes
Contributions withheld from employees
Revenue [Policy Text Block]
Revenue Recognition
Rani L L C [Member]
Rani LLC.
Rani LLC [Member]
Share-Based Payment Arrangement [Abstract]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Schedule of Related Party Transactions [Table Text Block]
Schedule of Amounts Charged for Services and Rent
Share Based Compensation Number Of Profits Interests Outstanding Number.
Share Based Compensation Number Of Profits Interests Outstanding Number
Number of Profit Interests, Balance at December 31, 2020
Number of Profit Interests, Balance at September 30, 2021
Debt Securities, Available-for-Sale, Total
Debt Securities, Available-for-Sale
Estimated Fair Value
Marketable Securities
Accounting Policies [Abstract]
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Summary Of Stock Option Activity
Summary of Stock Options and Options for Common Units Activity
Cash and Cash Equivalents [Line Items]
Income Tax Disclosure [Abstract]
Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]
Supplemental disclosures of non-cash investing and financing activities
Reimbursement of research and development expense
Recovery of Direct Costs
Statement [Table]
Statement [Table]
Increase (Decrease) in Prepaid Expenses, Other
Component of prepaid expenses
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest, Total
Comprehensive Income (Loss), Net of Tax, Attributable to Noncontrolling Interest
Comprehensive loss attributable to non-controlling interest
Comprehensive loss attributable to non-controlling interest
Comprehensive loss attributable to non-controlling interest
Subsequent Event [Table]
Agreement termination period
Agreement Termination Period
Agreement termination period
Preferred Stock, Shares Authorized
Units Authorized
Preferred stock authorized
Weighted average vesting term
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Weighted Average Vesting Period
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Weighted Average Vesting Period
Revenue from contract
Revenue from Contract with Customer, Including Assessed Tax
Securities Act File Number
Entity File Number
Net decrease in cash, cash equivalents and restricted cash equivalents
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Earnings Per Share [Abstract]
Interest income receivable
Interest Receivable
Warrants and Rights Outstanding, Term
Warrants exercisable period
2024 (remaining six months)
Long-Term Debt, Maturity, Remainder of Fiscal Year
Statement of Financial Position [Abstract]
Interest Expense, Total
Interest Expense, Operating and Nonoperating
Interest expense and other, net
IPO
IPO [Member]
IPO [Member]
Entity Incorporation, Date of Incorporation
Date of incorporation
Operating Income (Loss)
Loss from operations
Profits interests activity threshold
Share Based Compensation Arrangement By Share Based Payment Award Profits Interests Activity Threshold
Profits Interests Threshold, Balance at December 31, 2020
Profits Interests Threshold, Balance at September 30, 2021
Long-Term Debt, Maturity, Year One
2025
Offering price
Shares Issued, Price Per Share
Accrued Taxes
Accrued Income Taxes, Current
Income tax payable, amount
Par value
Common Stock, No Par Value
Entity Shell Company
Entity Shell Company
Summary of Significant Unobservable Inputs used in the Fair Value Measurement of the Series E Preferred Unit Warrant Liability
Summary of Significant Unobservable Inputs used in the Fair Value Measurement of the Series E Preferred Unit Warrant Liability
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
Entity Tax Identification Number
Entity Tax Identification Number
Assets [Abstract]
Assets:
Class of Warrant or Right [Domain]
Class of Warrant or Right
Fair Value of Financial Instruments, Policy [Policy Text Block]
Fair Value of Financial Instruments
Government [Member]
International government
Entity Current Reporting Status
Entity Current Reporting Status
Weighted Average Remaining Contractual Term, Exercisable at June 30, 2022 (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Cash Equivalents Restricted Cash Equivalents and Marketable Securities Policy Text Block
Cash Equivalents Restricted Cash Equivalents and Marketable Securities Policy Text Block
Cash Equivalents, Restricted Cash Equivalents and Marketable Securities
Subsequent Events [Abstract]
Share-based Compensation Arrangement by Share-based Payment Award Options Granted As Replacement Awards in Period Intrinsic Value.
Share-based Compensation Arrangement by Share-based Payment Award Options Granted As Replacement Awards in Period Intrinsic Value
Aggregate Intrinsic Value, Granted as replacement awards (in thousands)
Previously Reported [Member]
Previously Reported [Member]
The entire disclosure of warrants.
Warrants [Text Block]
Warrants
Document Fiscal Year Focus
Document Fiscal Year Focus
Preferred stock, $0.0001 par value - 20,000 shares authorized; none issued and outstanding as of June 30, 2024 and December 31, 2023
Preferred Stock, Value, Issued, Ending Balance
Preferred Stock, Value, Issued, Beginning Balance
Preferred Stock, Value, Issued, Total
Preferred Stock, Value, Issued
Carrying Value
Property and equipment purchases included in accounts payable and accrued expenses and other current liabilities
Capital Expenditures Incurred but Not yet Paid
City Area Code
City Area Code
Liabilities, Current
Total current liabilities
Accrued expenses and other current liabilities
Accrued Liabilities and Other Liabilities
Restricted Cash Equivalents, Fair Value Disclosure
Restricted Cash Equivalents, Fair Value Disclosure
Restricted Cash Equivalents
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Local Phone Number
Local Phone Number
Preferred Stock, Shares Outstanding, Ending Balance
Preferred Stock, Shares Outstanding, Beginning Balance
Preferred Stock, Shares Outstanding
Units Outstanding
Preferred stock outstanding
Accrued Salaries
Payroll and related
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Amount payable for services.
Amount Payable For Evaluation Services
Amount payable for evaluation services
Summary of significant accounting policies.
Summary Of Significant Accounting Policies [Table]
Summary Of Significant Accounting Policies [Table]
Additional paid-in capital
Additional Paid in Capital, Total
Additional Paid in Capital, Beginning Balance
Additional Paid in Capital, Ending Balance
Additional Paid in Capital
Issuance of common stock under employee equity plans, net of shares withheld for tax settlement , shares
Restricted Stock, Shares Issued Net of Shares for Tax Withholdings
Evaluation Agreements
Evaluation Agreements [Text Block]
The entire disclosure for evaluation agreements.
Commitments and Contingencies Disclosure [Abstract]
Registration Rights Agreement [Member]
Registration Rights Agreement [Member]
Convertible Preferred Units
Convertible Preferred Stock [Member]
Convertible Preferred [Member]
Debt Securities, Available-for-Sale, Amortized Cost, Total
Debt Securities, Available-for-Sale, Amortized Cost
Amortized cost
Less: Current portion of operating lease liability
Current portion of operating lease liability
Operating Lease, Liability, Current
Document Information [Line Items]
Limited Liability Company (LLC) Preferred Unit, Issued
Convertible Preferred units issued
Retained Earnings [Member]
Accumulated Deficit [Member]
Members Deficit [Member]
Amortization of Debt Issuance Costs and Discounts, Total
Amortization of Debt Issuance Costs and Discounts
Amortization of debt discount and issuance costs
Prepaid Expenses and Other Current Assets [Member]
Prepaid Expenses and Other Current Assets [Member]
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment, Total
Payments to Acquire Property, Plant, and Equipment
Document Transition Report
Document Transition Report
Accumulated Other Comprehensive Loss Member
Accumulated Other Comprehensive Loss Member
Accumulated Other Comprehensive Loss Member
Long-Term Debt, Unclassified [Abstract]
Lessee, Operating Lease, Liability, to be Paid, Year Two
2023 (totaled)
2025
Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Additional Cash Flow Elements [Abstract]
Cash Flows
Limited Liability Company (LLC) Preferred Unit, Authorized
Convertible Preferred units authorized
Proceeds from employee stock purchase plan
Proceeds from Stock Plans
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Concentrations of Credit Risk and Other Risks and Uncertainties
Minimum
Minimum [Member]
Minimum
Common Unit
Common [Member]
Common Stock [Member]
Long-Term Debt, Maturity, Year Two
2026
Accrued Expenses and Other Current Liabilities
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Share Based Compensation Number Of Profits Interests Canceled And Replaced With Restricted Stock Awards.
Share Based Compensation Number Of Profits Interests Canceled And Replaced With Restricted Stock Awards
Number of Profit Interests, Canceled and replaced with restricted stock awards
Cancelled
Sales price and fair value of common units, difference amount.
Sales Price And Fair Value Of Common Units Difference Amount
Sales price and fair value of common units, difference
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
Outstanding, Weighted-Average Grant Date Fair Value
Outstanding, Weighted-Average Grant Date Fair Value
Operating Lease, Right-of-Use Asset, Periodic Reduction
Non-cash operating lease expense
Additional Paid-in Capital [Member]
Additional Paid in Capital [Member]
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Adjustments to reconcile net loss to net cash used in operating activities:
Statement of Income Location, Balance [Domain]
Income Statement Location
2024 (remaining six months)
Lessee, Operating Lease, Liability, to be Paid, Year One
2022 (remaining three months)
Other Assets, Noncurrent
Other assets
Outstanding Capital Class A Unit [Member]
Outstanding Capital Class A Unit [Member]
Other Prepaid Expense, Current
Prepaid expenses and other current assets
Proceeds from Sale of Debt Securities, Available-for-Sale
Debt Securities, Available-for-Sale
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Disaggregation of Revenue [Line Items]
Stockholders' Equity Attributable to Noncontrolling Interest, Total
Stockholders' Equity Attributable to Noncontrolling Interest, Beginning Balance
Stockholders' Equity Attributable to Noncontrolling Interest, Ending Balance
Equity, Attributable to Noncontrolling Interest
Non-controlling interest
Repurchase Agreements, Resale Agreements, Securities Borrowed, and Securities Loaned Disclosure [Text Block]
Evaluation Agreements
Series B Common Warrants [Member]
Series B Common Warrants [Member]
Series B Common Warrants Member
Fair value totaling
Warrants and Rights Outstanding
Share Based Compensation Number Of Profits Interests Grants In Period Gross.
Share Based Compensation Number Of Profits Interests Grants In Period Gross
Number of Profit Interests Granted
Pre-Funded Warrant [Member]
Pre Funded Warrant [Member]
Pre Funded Warrant Member
Common stock units issued
Common Stock, Value, Issued, Ending Balance
Common Stock, Value, Issued, Beginning Balance
Common Stock, Value, Issued, Total
Common Stock, Value, Issued
Common stock, value
Fair value measurement probability of exit events.
Fair Value Measurement Probability Of Exit Events
Fair value measurement probability of exit events
Stock Issued During Period, Value, Conversion of Units
Non-controlling interest adjustment for changes in proportionate ownership in Rani LLC
Cash and Cash Equivalents, Fair Value Disclosure
Cash Equivalents
Cash and Cash Equivalent [Table]
Capitalization, Long-Term Debt and Equity, Total
Capitalization, Long-Term Debt and Equity
Market capitalization amount
Preferred Units, Class [Domain]
Preferred Units, Class
2026
Long-Term Debt, Maturity, Year Three
Operating Lease, Liability
Total operating lease liability
Lease liability
Tax Receivable Agreement, Policy [Policy Text Block]
Tax Receivable Agreement, Policy [Policy Text Block]
Tax Receivable Agreement
Measurement Frequency [Axis]
Measurement Frequency
Schedule of Accrued Liabilities [Table Text Block]
Schedule of Accrued Expenses
Commitments and contingencies (Note 11)
Commitments and Contingencies
Weighted-average share outstanding diluted
Weighted Average Number of Shares Outstanding, Diluted
Weighted Average Number of Shares Outstanding, Diluted, Total
Weighted average Class A common share outstanding-diluted
Significant Accounting Policies [Text Block]
Summary of Significant Accounting Policies
Significant Accounting Policies
Lessee, Operating Lease, Renewal Term
Lessee, Operating Lease, Renewal Term
Future minimum lease payments
Lessee, Operating Lease, Liability, to be Paid
Total undiscounted future minimum lease payments
Total undiscounted future minimum lease payments
Tabular disclosure for profits interests activity.
Schedule Of Share Based Compensation Profits Interests Activity Table [Text Block]
Summary of Profits Interests Activity
Share Based Compensation Profit Interests Canceled And Replaced With Restricted Stock Awards Weighted Average Grant Date Fair Value.
Share Based Compensation Profit Interests Canceled And Replaced With Restricted Stock Awards Weighted Average Grant Date Fair Value
Weighted Average Grant Date Fair Value, Canceled and replaced with restricted stock awards
Continuing LLC Owners
Continuing LLC Owners [Member]
Share Based Compensation Number Of Profits Interests Forfeitures.
Share Based Compensation Number Of Profits Interests Forfeitures
Number of Profit Interests Forfeited
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Comprehensive loss attributable to Rani Therapeutics Holdings, Inc.
Comprehensive loss
Comprehensive loss
Entity Small Business
Entity Small Business
Limited Liability Company (LLC) Preferred Unit, Outstanding
Convertible Preferred units outstanding
US Treasury Securities [Member]
U.S. Treasuries
Operating Leases, Rent Expense, Total
Operating Leases, Rent Expense
Rent expense
2021 Employee Stock Purchase Plan
Two Thousand And Twenty One Employee Stock Purchase Plan [Member]
Two Thousand And Twenty One Employee Stock Purchase Plan [Member]
Credit Facility [Axis]
Novartis Agreement [Member]
Novartis Agreement [Member]
Novartis Agreement [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period, Intrinsic Value
Amount of accumulated difference between fair value of underlying shares on dates of grant and grant price on options granted (or share units converted) into shares.
Aggregate Intrinsic Value, Granted (in thousands)
Service agreement term
Service Agreement Term
Service agreement term.
Accretion (Amortization) of Discounts and Premiums, Investments
Net accretion and amortization of investments in marketable securities
Compensation Related Costs, Policy [Policy Text Block]
Equity-Based Compensation
Net Cash Provided by (Used in) Financing Activities [Abstract]
Cash flows from financing activities
Stock options, outstanding, weighted average exercise price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Weighted Average Exercise Price per Share, Outstanding, Ending balance
Weighted Average Exercise Price per Share, Outstanding, Beginning balance
Debt Security, Government, Non-US [Member]
International goverment
Restricted Cash Equivalents [Member]
Restricted Cash Equivalents [Member]
Asset Class [Axis]
Common Unit, Authorized
Common units, authorized
Common Unit Authorized
Exchanges Of Paired Interests And Non-Corresponding Class A Units
Exchanges Of Paired Interests And Non-Corresponding Class A Units
Exchanges of non-corresponding Class A Units of Rani LLC
Right- of- use asset obtained in exchange for new operating lease liabilities
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Measurement Frequency [Domain]
Measurement Frequency
Aggregate desired patent acquisition
Aggregate desired patent acquisition
Aggregate desired patent acquisition
Fair Value, Inputs, Level 3 [Member]
Level 3
Weighted-average remaining lease term (in years)
Operating Lease, Weighted Average Remaining Lease Term
Service agreement remaining term
Subsequent Events
Subsequent Events [Text Block]
Equity-Based Compensation
Share-Based Payment Arrangement [Member]
Members' Deficit [Member]
Members' Deficit.
Members' Deficit [Member]
Accounts Payable, Current, Total
Accounts Payable, Current
Accounts payable
Capital Unit, Class [Domain]
Deferred offering costs
Deferred Offering Costs
Liabilities, Fair Value Disclosure, Total
Total liabilities
Liabilities, Fair Value Disclosure
Financial liabilities measured at fair value
Accrued expenses and other current liabilities
Increase (Decrease) in Accrued Liabilities, Total
Increase (Decrease) in Accrued Liabilities